CognitiveCare Inc, a healthcare technology company, announced its novel patent for Maternal and Infant Health Insight and Cognitive Intelligence.
The predictive MIHIC Score system uses multimodal data sources to anticipate the probability of 48 maternal, fetal and infant risks. The AI-driven solution aims to improve individual and population health while maximizing provider, public health organization, payer and pharmaceutical entity resource allocation.
Preceding the recent patent approval, CognitiveCare Inc named Errol Norwitz, MD, PhD, as its chief innovation and impact officer. Having spent five years on CognitiveCare Inc's Board of Advisors, Dr. Norwitz was a key player in the development of MIHIC.